Nu-Med Plus (NUMD) Free Cash Flow (2012 - 2025)
Nu-Med Plus' (NUMD) quarterly Free Cash Flow came in at -$35054.0 in Q4 2025, down 2001.56% year-on-year from $1843.4 in Q4 2024, and down 207.09% quarter-over-quarter from -$11415.0 in Q3 2025.
Nu-Med Plus (NUMD) Free Cash Flow (2012 - 2025) Analysis & Trends
Nu-Med Plus has disclosed Free Cash Flow across 14 years of filings, most recently posting -$35054.0 for Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$35054.0, down 2001.56% year-over-year; the trailing twelve-month figure through Dec 2025 was -$46469.0 (down 948.25% YoY), and the FY2025 annual result was -$47979.0, down 982.31% from the prior year.
- Free Cash Flow came in at -$35054.0 for Q4 2025 at Nu-Med Plus, down from -$11415.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $628.0 in Q3 2022 to a low of -$79241.0 in Q1 2021.
- The 5-year median for Free Cash Flow is -$18869.0 (2023), against an average of -$21329.5.
- Across the five-year window, Free Cash Flow surged 101.53% in 2022 and plunged 3104.62% in 2023, its largest moves.
- Nu-Med Plus' Free Cash Flow stood at -$20165.0 in 2021, then fell by 21.17% to -$24433.0 in 2022, then jumped by 82.47% to -$4282.0 in 2023, then soared by 61.05% to -$1668.0 in 2024, then tumbled by 2001.56% to -$35054.0 in 2025.
- The last three Free Cash Flow figures came in at -$35054.0 (Q4 2025), -$11415.0 (Q3 2025), and -$1668.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -21.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 204.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 449.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Nu-Med Plus | - | - | - | -35,054.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -35,054.00 |
| Dec 31, 2025 | -35,054.00 |
| Sep 30, 2025 | -11,415.00 |
| Sep 30, 2025 | -11,415.00 |
| Dec 31, 2024 | -1,668.00 |
| Dec 31, 2024 | -1,668.00 |
| Jun 30, 2024 | -2,315.00 |
| Jun 30, 2024 | -2,315.00 |
| Mar 31, 2024 | -450.00 |
| Mar 31, 2024 | -450.00 |
| Dec 31, 2023 | -4,282.00 |
| Dec 31, 2023 | -4,282.00 |
| Sep 30, 2023 | -18,869.00 |
| Sep 30, 2023 | -18,869.00 |
| Jun 30, 2023 | -23,072.00 |
| Jun 30, 2023 | -23,072.00 |
| Mar 31, 2023 | -20,166.00 |
| Mar 31, 2023 | -20,166.00 |
| Dec 31, 2022 | -24,433.00 |
| Dec 31, 2022 | -24,433.00 |